The influence of α-, β-, and γ-melanocyte stimulating hormone on acetaminophen induced liver lesions in male CBA mice

Molecules

Volumn 15, Issue 3, 2010, Pages 1232-1241

  Blagaić, Vladimir ^a   Houra, Karlo ^b   Turčić, Petra ^c   Štambuk, Nikola ^d   Konjevoda, Paško ^d   Boban Blagaić, Alenka ^e   Kelava, Tomislav ^e   Kos, Marina ^b   Aralica, Gorana ^f   Čulo, Filip ^e  

^a University Hospital Sveti Duh   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

^d RUDER BO KOVI INSTITUTE   (Croatia)

^e UNIVERSITY OF ZAGREB   (Croatia)

^f University of Zagreb   (Croatia)

Author keywords

Acetaminophen; Alpha MSH; Beta MSH; Gamma MSH; Liver; Melanocortins

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERMEDIN; ASPARTATE AMINOTRANSFERASE; BETA INTERMEDIN; CORTICOTROPIN; GAMMA INTERMEDIN; PARACETAMOL;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BLOOD; CBA MOUSE; CHEMISTRY; DOSE RESPONSE; ENZYMOLOGY; MALE; MOLECULAR GENETICS; MOUSE; TOXIC HEPATITIS;

ACETAMINOPHEN; ADRENOCORTICOTROPIC HORMONE; ALANINE TRANSAMINASE; ALPHA-MSH; AMINO ACID SEQUENCE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BETA-MSH; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-INDUCED LIVER INJURY; GAMMA-MSH; MALE; MICE; MICE, INBRED CBA; MOLECULAR SEQUENCE DATA;

EID: 77950363061     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15031232     Document Type: Article

References (33)

1. Kumar, V.; Abbas A. K.; Fausto, N.; Mitchell R. N. Robbins Basic Pathology; Saunders: Philadelphia, PA, USA, 2007; pp. 639-648.
2. Lange, C.; Sarrazin, C. New agents for treatment. In Hepatology: A Clinical Textbook; Mauss, S., Berg, T., Rockstroh, J., Sarrazin, C., Wedemeyer, H., Eds.; Flying Publisher: Düsseldorf, Germany, 2009, pp. 211-244.
3. Brzoska, T.; Luger, T. A.; Maaser, C.; Abels, C.; Böhm, M. Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr. Rev. 2008, 29, 581-602.
4. Getting, S. J. Targeting melanocortin receptors as potential novel therapeutics. Pharmacol. Ther. 2006, 111, 1-15. (Pubitemid 43765537)
5. Lee, D. J.; Biros, D. J.; Taylor, A. W. Injection of an alpha-melanocyte stimulating hormone expression plasmid is effective in suppressing experimental autoimmune uveitis. Int. Immunopharmacol. 2009, 9, 1079-1086.
6. Kokot, A.; Sindrilaru, A.; Schiller, M.; Sunderkötter, C.; Kerkhoff, C.; Eckes, B.; Scharffetter-Kochanek, K.; Luger, T. A.; Böhm, M. alpha-melanocyte-stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma: Melanocortin peptides as a novel treatment strategy for scleroderma? Arthritis Rheum. 2009, 60, 592-603.
7. Getting, S. J.; Riffo-Vasquez, Y.; Pitchford, S.; Kaneva, M.; Grieco, P.; Page, C. P.; Perretti, M.; Spina, D. A role for MC3R in modulating lung inflammation. Pulm. Pharmacol. Ther. 2008, 21, 866-873.
8. Lasaga, M.; Debeljuk, L.; Durand, D.; Scimonelli, T. N.; Caruso, C. Role of alpha-melanocyte stimulating hormone and melanocortin 4 receptor in brain inflammation. Peptides 2008, 29, 1825-1835.
9. Böhm, M.; Luger, T. A.; Tobin, D. J.; Garcia-Borron, J. G. Melanocortin receptor ligands: New horizons for skin biology and clinical dermatology. J. Invest. Dermatol. 2006, 126, 1966-1975. (Pubitemid 44244841)
10. Scholzen, T. E.; Sunderkotter, C.; Kalden, D. H.; Brzoska, T.; Fastrich, M.; Fisbeck, T.; Armstrong, C. A.; Ansel, J. C., Luger, T. A. α-Melanocyte stimulating hormone prevents lipopolysaccharide-induced vasculitis by down-regulating endothelial cell adhesion molecule expression. Endocrinology 2003, 144, 360-370.
11. Spencer, J. D.; Schallreuter, K. U. Regulation of pigmentation in human epidermal melanocytes by functional high-affinity ß-melanocyte-Stimulating hormone/melanocortin-4 receptor signaling. Endocrinology 2009, 150, 1250-1258.
12. Bertolini, A.; Tacchi, R.; Vergoni, A. V. Brain effects of melanocortins. Pharmacol. Res. 2009, 59, 13-47.
13. Wang, C. H.; Lee, T. H.; Lu, C. N.; Chou, W. Y.; Hung, K. S.; Concejero, A. M.; Jawan, B. Electroporative alpha-MSH gene transfer attenuates thioacetamide-induced murine hepatic fibrosis by MMP and TIMP modulation. Gene Ther. 2006, 13, 1000-1009.
14. Lee, T, H.; Jawan, B.; Chou, W. Y.; Lu, C. N.; Wu, C. L.; Kuo, H. M.; Concejero, A. M.; Wang, C. H. Alpha-melanocyte-stimulating hormone gene therapy reverses carbon tetrachloride induced liver fibrosis in mice. J. Gene Med. 2006, 8, 764-772.
15. Wang, C. H.; Jawan, B.; Lee, T. H.; Hung, K. S., Chou, W. Y.; Lu, C. N.; Liu, J. K.; Chen, Y. J. Single injection of naked plasmid encoding alpha-melanocyte-stimulating hormone protects against thioacetamide-induced acute liver failure in mice. Biochem. Biophys. Res. Commun. 2004, 322, 153-161.
16. Chiao, H.; Foster, S.; Thomas, R.; Lipton, J.; Star, R. A. Alpha-melanocyte-stimulating hormone reduces endotoxin-induced liver inflammation. J. Clin. Invest. 1996, 97, 2038-2044.
17. Nelson, S. D.; Bruschi S. A. Mechanisms of acetaminophen-induced liver disease. In Drug-Induced liver disease; Kaplowitz, N., DeLeve, L. D, Eds.; Informa Healthcare: New York, NY, USA, 2007; pp. 353-388.
18. Timbrel, J. A. Principles of Biochemical Toxicology; Informa Healthcare: New York, NY, USA, 2009; pp. 313-321.
19. Guarner, F.; Boughton-Smith, N. K.; Blackwell, G. J.; Moncada, S. Reduction by prostacyclin of acetaminophen-induced liver toxicity in the mouse. Hepatology 1988, 8, 248-253.
20. Čulo, F.; Renić, M.; Sabolović, D.; Radoš, M.; Bilić, A.; Jagić, V. Ketoconazole inhibits acetaminophen-induced hepatotoxicity in mice. Eur. J. Gastroenterol. Hepatol. 1995, 7, 757-762.
21. Silva, V. M.; Chen, C.; Hennig, G. E.; Whiteley, H. E.; Manautou, E. J. Changes in susceptibility to acetaminophen-induced liver injury by the organic anion indocyanine green. Food. Chem. Tox. 2001, 3, 271-278.
22. Manautou, J. E.; Silva, V. M.; Hennig, G. E.; Whiteley, H. E. Repeated dosing with the peroxisome proliferation clofibrate decreases the toxicity of model hepatotoxic agents in male mice. Toxicology 1998, 172, 1-10.
23. Turčić, P.; Bradamante, M.; Houra, K.; Štambuk, N.; Kelava, T.; Konjevoda, P.; Kazazić, S.; Vikić-Topić, D.; Pokrić, B. Effects of α-melanocortin enantiomers on acetaminophen induced hepatotoxicity in CBA mice. Molecules 2009, 14, 5017-5026.
24. Kastin, A. J.; Pan, W. Peptides and hormesis. Crit. Rev. Toxicol. 2008, 38, 629-631.
25. Kilty, C. G.; Keenan, J.; Shaw, M. Histologically defined biomarkers in toxicology. Expert Opin. Drug Saf. 2005, 6, 207-215.
26. Patrick, G. Instant Notes Medicinal Chemistry; Bios: Oxford, UK, 2001; pp. 61-73.
27. Talarida, R. J. Drug Synergism and Dose-effect Analysis; Chapman & Hall/CRC: Boca Raton, FL, USA, 2000; pp. 21-40.
28. Muceniece, R.; Zvejniece, L.; Kirjanova, O.; Liepinsh, E.; Krigere, L.; Baumane, L.; Kalvinsh, I.; Wikberg, J. E. S.; Dambrova, M. β-and γ-melanocortins inhibit lipopolysaccharide induced nitric oxide production in mice brain. Brain Res. 2004, 995, 7-13.
29. Ping-Lim, S.; Andrews, F. J.; O'Brien, P. E. Misoprostol protection against acetaminophen-induced hepatotoxicity in the rat. Dig. Dis. Sci. 1994, 39, 1249-1256.
30. Newsome, P. N.; Plevris, J. N.; Nelson, L. N.; Hayes, P. C. Animal models of fulminant hepatic failure: A critical evaluation. Liver Transpl. 2000, 6, 21-31.
31. Rowe, P. Essential Statistics for the Pharmaceutical Sciences; Wiley: Chichester, UK, 2007; pp. 195-242.
32. KyensLab Inc, Tokyo, Japan. http://www.kyenslab.com/, accessed 17 September 2009.
33. GraphPad Software, San Diego, CA, USA. http://www.graphpad.com/, accessed 17 September 2009.